—

GALDERMA GROUP AG (GALDY) — the peer cohort

As of 2026-11-02 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

GALDERMA GROUP AG ranks 3 of 7 in its cohort on the Closelooknet composite (56/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 62/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALDY GALDERMA GROUP AG 56 71 59 22 ok 1%
ROVI.MC Laboratorios Farmaceuticos ROVI 62 46 77 48 info 25.7%
LNTH Lantheus Holdings Inc 60 72 73 55 ok 10.3%
KNSA Kiniksa Pharmaceuticals Ltd 56 91 58 18 ok 7.8%
ALM.MC Almirall S.A. 55 39 46 66 info 22.2%
IRWD Ironwood Pharmaceuticals Inc 55 25 77 84 warn 40.1%
FAGR.BR Fagron NV 54 60 56 58 info 6.9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-02

Quick answers

Who are GALDERMA GROUP AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Kiniksa Pharmaceuticals Ltd (KNSA), Almirall S.A. (ALM.MC), Ironwood Pharmaceuticals Inc (IRWD), Fagron NV (FAGR.BR), as of 2026-11-02.

How does GALDY score against its peers?

GALDERMA GROUP AG's composite reads 56/100, ranking 3 of 7 in its cohort as of 2026-11-02; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 62/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.